Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

At-Home Transcutaneous Auricular Neuromodulation for Hypermobile Ehlers Danlos Syndrome

NCT06105541 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT06105541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06105541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
At-Home Transcutaneous Auricular Neuromodulation for Hypermobile Ehlers Danlos Syndrome
Lead sponsor
Medical University of South Carolina
Phase
Not applicable
Overall status
Completed
Start date
July 5, 2023
Completion date
February 4, 2026
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ehlers-danlos syndrome, hypermobile ehlers-danlos syndrome, hypermobile spectrum disorder